Kalbe Farma traded at 825.00 this Thursday August 20th, increasing 45.00 or 5.77 percent since the previous trading session. Looking back, over the last four weeks, Kalbe Farma gained 10.74 percent. Over the last 12 months, its price fell by 41.49 percent. Looking ahead, we forecast Kalbe Farma to be priced at 766.64 by the end of this quarter and at 674.68 in one year, according to Trading Economics global macro models projections and analysts expectations.
PT Kalbe Farma Tbk is an Indonesia-based pharmaceutical company. The Company provides healthcare solution through its four business divisions: the prescription pharmaceutical division, consumer health, nutritional, and distribution and logistics divisions. Its Prescription Pharmaceuticals division provides a range of products for all groups, from unbranded generic drugs for the mass-market segment, to branded generics and licensed drugs. The Consumer Health division's product portfolio spans from over-the-counter (OTC) drugs and energy drinks to a selection of ready-to-drink healthy beverage products. The Nutritional division manages a range of nutritional products, comprising of powdered milk products for all age segments: infants, toddlers, children, pre-teenagers, teenagers, adults, pregnant and lactating women. Its Distribution and Logistics Division operates the distribution coverage for pharmaceuticals products in Indonesia.